Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Bevacizumab and Abraxane as Second-line Therapy in Triple Negative Metastatic Breast Cancer

Abramson Cancer Center at Penn Medicine · 2007
ClinicalTrials.gov · Datasets · License: Public Domain · 2007
Open Source ↗
breast-cancer
breast cancer, metastatic breast cancer, second-line therapy, triple negative, her-2 negative, hormone receptor negative, abraxane, bevacizumab, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 885276
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.